| Celestial Biolabs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532871 |
NSE Symbol : - |
P/E(TTM) : - |
|
ISIN Demat : INE221I01017 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : 1.17 |
Market Cap(₹Cr) : 4.56 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.04 | 0.04 | 0.02 | 0.04 | 0.03 | 0.04 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.04 | 0.04 | 0.02 | 0.04 | 0.03 | 0.04 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.04 | 0.04 | 0.02 | 0.04 | 0.03 | 0.04 |
| Total Expenditure | 0.07 | 0.06 | 0.12 | 0.27 | 0.18 | 0.12 |
| PBIDT | -0.03 | -0.03 | -0.09 | -0.23 | -0.14 | -0.07 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | -0.03 | -0.03 | -0.09 | -0.23 | -0.15 | -0.08 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -0.03 | -0.03 | -0.10 | -0.24 | -0.15 | -0.08 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.03 | -0.03 | -0.10 | -0.24 | -0.15 | -0.08 |
| EPS (Unit Curr.) | -0.02 | -0.01 | -0.04 | -0.10 | -0.07 | -0.04 |
| EPS (Adj) (Unit Curr.) | -0.02 | -0.01 | -0.04 | -0.10 | -0.07 | -0.04 |
| Calculated EPS (Unit Curr.) | -0.02 | -0.01 | -0.04 | -0.10 | -0.07 | -0.04 |
| Calculated EPS (Adj) (Unit Curr.) | -0.02 | -0.01 | -0.04 | -0.10 | -0.07 | -0.04 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.06 | -0.06 | -0.17 | -0.42 | -0.27 | -0.15 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.06 | -0.06 | -0.17 | -0.42 | -0.27 | -0.15 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 22.59 | 22.59 | 22.59 | 22.59 | 22.59 | 22.59 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -75.00 | -75.00 | -450.00 | -575.00 | -466.67 | -175.00 |
| PBDTM(%) | -75.00 | -75.00 | -450.00 | -575.00 | -500.00 | -200.00 |
| PATM(%) | -75.00 | -75.00 | -500.00 | -600.00 | -500.00 | -200.00 |